Recalled Medicines & supplements – Current GIS Alerts 2026
Found 713 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Tirosint Sol
Due to the reduced content of the active substance in the specified batches, the risk to patient health from decreased medicinal efficacy cannot be excluded. Potential effects: ineffective treatment of thyroid disorders, worsening of hypothyroidism symptoms, cardiovascular complications in susceptible patients.
Tirosint Sol
Due to the reduced content of the active substance in these batches, the risk to patient health resulting from decreased effectiveness of the medicine cannot be excluded. Potential effects: reduced effectiveness of thyroid hormone therapy, possible worsening of hypothyroidism symptoms.
Tirosint Sol
Due to the reduced content of the active substance found in these batches, the risk to patient health resulting from decreased effectiveness of the medicine cannot be ruled out. Potential effects: ineffective treatment of hypothyroidism, worsening of disease symptoms, health complications.
Tirosint Sol
Reduced content of the active substance – levothyroxine sodium – was found in the listed batches, which may lead to decreased effectiveness of the medicine and a health risk for the patient. Potential effects: reduced efficacy of hypothyroidism treatment, deterioration of health, recurrence of disease symptoms.
Tirosint Sol
Due to the reduced content of the active substance found in these batches, a risk to patient health arising from decreased drug effectiveness cannot be excluded. Potential effects: reduced treatment efficacy, possible worsening of thyroid disease symptoms.
Tirosint Sol
Due to the reduced content of the active substance in the listed batches, the risk to patient health resulting from decreased effectiveness of the medicine cannot be excluded. Potential effects: ineffective treatment, exacerbation of thyroid disease, hormonal complications.
Tirosint Sol
Due to the reduced content of the active substance found in these batches, a health risk for the patient resulting from decreased efficacy of the medicine cannot be excluded. Potential effects: reduced effectiveness of hypothyroidism treatment, worsening of health status, possible complications.
Tirosint Sol
Due to the reduced content of the active substance in these batches, a risk to patient health from decreased therapeutic efficacy cannot be excluded. Potential effects: lack of treatment efficacy, worsening of health condition.
ADRENALIN OSEL (Adrenaline), 1 mg/1 mL IM/IV/SC Solution for Injection, Ampułka a 1 mg/ml,
Based on the collected data there is a risk to patients’ health and life due to the inability to use this life‑saving medicine and the possibility of administering a solution contaminated with glass. Potential effects: life‑threatening complications, tissue damage, acute systemic reactions.
ADRENALIN OSEL 1 mg/1 mL IM/IV/SC Solution for Injection
Breaking of the ampoule and inability to open the medicine normally, creating uncertainty whether glass fragments entered the interior and contaminated the solution, posing a threat to the patient’s health and life. Potential effects: life‑threatening complications after injection, tissue damage, lack of effective treatment.
Tirosint Sol
Due to the reduced active substance content found in these batches, a risk to patient health from decreased medicinal efficacy cannot be excluded. Potential effects: reduced treatment efficacy, disease worsening, complications related to insufficient therapy.
Tirosint Sol
Due to the reduced content of the active substance found in the above-mentioned batches, a risk to patient health arising from decreased effectiveness of the medicine cannot be ruled out. Potential effects: lack of treatment efficacy, worsening of disease symptoms.
Tirosint Sol
A reduced content of the active substance (levothyroxine) was found in five batches, with out-of-specification results and levels below the established limit, which may lead to decreased drug effectiveness and health risk for patients. Potential effects: reduced efficacy of hypothyroidism treatment, possible worsening of disease symptoms.
Tirosint Sol
Due to the reduced active substance content found in the above-mentioned batches, a risk to patient health from decreased efficacy of the medicine cannot be excluded. Potential effects: lack of treatment effectiveness, worsening disease control, possible complications of thyroid disorders.
Tirosint Sol
A decrease in active substance content below the limit and out-of-specification results for levothyroxine content were found, which may lead to reduced effectiveness of the medicine, and a risk to patient health cannot be excluded. Potential effects: reduced treatment effectiveness, worsening of disease symptoms, possible complications resulting from hypothyroidism.
Lorabex
Suspected quality defect: out-of-specification (OOS) results for the parameters Lorazepam content and Lorazepam related substances, which may indicate an incorrect amount of active substance and impurities in the solution for injection. Potential effects: lack of treatment efficacy, excessive sedative effect, adverse reactions, complications.
Diprophos
Possible occurrence of brown, metallic-looking particles in the suspension for injection, identified as stainless steel particles, which may cause local inflammatory conditions and hypersensitivity reactions at the injection site. Potential effects: local complications, inflammation, allergic reactions, post-procedural complications.
Diprophos
A possible occurrence of brown particles with a metallic appearance, identified as stainless steel particles, was found in the suspension for injection. Potential effects: local inflammatory reactions, hypersensitivity, complications after injection of foreign bodies.
Bupicain
The information leaflet for Bupicain contains incorrect data on the possibility of intravenous and intra-arterial administration of the medicine, which is associated with a threat to public health. Potential effects: incorrect administration, severe complications, life-threatening events.
Febrisan
An out-of-specification result was found in stability testing: at 12 months the content limits for paracetamol and ascorbic acid were exceeded; it is uncertain whether the rest of the batch meets quality requirements for active substance content. Potential effects: reduced treatment efficacy or increased adverse effects.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.